Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)

This study has been completed.
Sponsor:
Collaborators:
AstraZeneca
Respiratory Technology Corporation
Information provided by (Responsible Party):
Adam Klein, Emory University
ClinicalTrials.gov Identifier:
NCT00321503
First received: May 2, 2006
Last updated: December 6, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)